Decidual vasculopathy in preeclampsia 3A: Prediction and early detection (pilot study)

Decidual vasculopathy in preeclampsia 3A: Prediction and early detection (pilot study) - DEVAP 3A

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35575

Enrollment

Registered

2012-02-03

Start date

2012-05-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HELLP syndrome preeclampsia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who are admitted at Radboud University Nijmegen Medical Centre with the diagnosis of preeclampsia.

Exclusion criteria

Exclusion criteria: Multiple pregnancies, signs of intra-uterine infection, chomosomal abnormalities of the fetus.

Design outcomes

Primary

Measure	Time frame
Levels of biomarkers and bilateral uterine artery flow in multiples of the median (for details see page 12 of research protocol).	—

Secondary

Measure	Time frame
Levels of biomarkers in multiples of the median (for details see page 12 of research protocol)	—

Countries

Netherlands

Outcome results